Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-04

Clinical Trial Update: Treximet Early Intervention Adolescent Migraine [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating Treximet for early intervention in adolescents with migraine has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: Premiere Research Institute | Conditions: Migraine | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-05-04